Concepedia

Jessica Oddo

JO

Statistics

Publications

6

Citations

688

H-Index

6

Active since

2011

Affiliations

Oncotide Pharmaceuticals (United States)(Current)

Duke Medical Center

Oregon Health & Science University

Jessica Oddo is an author at Oncotide Pharmaceuticals (United States) specializing in oncology, medicine, and protein phosphatase 2a regulation.

Publications per year

2011–2014

6

Publications

6

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

Mahnaz Janghorban, Amy Farrell, Brittany L. Allen-Petersen et al. · Proceedings of the National Academy of Sciences · 2014 · 190 citations · Full text

, , +17

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target

Dale J. Christensen, Youwei Chen, Jessica Oddo et al. · Blood · 2011 · 128 citations · Full text

, , +12

Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia

Anupriya Agarwal, Ryan J. MacKenzie, Raffaella Pippa et al. · Clinical Cancer Research · 2014 · 124 citations

, , +17

Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A

Dale J. Christensen, Nobutaka Ohkubo, Jessica Oddo et al. · The Journal of Immunology · 2011 · 120 citations

, , +17

Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer

Amy Farrell, Brittany L. Allen-Petersen, Colin J. Daniel et al. · Molecular Cancer Research · 2014 · 112 citations · Full text

, , +17

1–5 of 6